retatrutide fda approval status eli lilly Remember, it is still in Phase 3 trial. Not yet approved. Expected to be approved in 2027 or early 2028 Lilly's new diabetes drug doubled

The table below walks through the typical dose adjustment guidance based on how much weight youve lost over the two-week period and when to reach out for more support

Focus on Recovery: By minimizing financial worries, you can fully immerse yourself in the therapeutic process and commit to your healing without distraction

Although the data are preliminary and mixed, this area shows promising potential (Sola-Leyva et al., 2024)

In other words, we may become very good at shrinking bodies without necessarily improving long-term human performance

Connecting insufficient sleep and insomnia with metabolic dysfunction

What providers need to know: June 2025 GLP-1 trends & updates